Sign inJoin waitlistJoin the waitlist

Ronald Levy

Robert K. and Helen K. Summy Professor in the School of Medicine · School of Medicine

Credentials: · · · · ·

History

School of Medicine
Present

Stanford University School of Medicine
Until 1973
Massachusetts General Hospital
Until 1970
Massachusetts General Hospital
Until 1969
Stanford University School of Medicine
1968
Harvard University
1963

Research

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Nature · 2000 · 6,794 citations
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
Journal of Clinical Oncology · 1998 · 2,302 citations

Izidore Lossos
46 papers
RW
Roger Warnke
46 papers
Ash Alizadeh
33 papers · 9 as a resident
Holbrook Kohrt
33 papers
John Timmerman
21 papers
KF
Kenneth Frankel
21 papers
Yasodha Natkunam
20 papers
David Maloney
19 papers · 7 as a fellow
Joshua Brody
17 papers
Gary Steinberg
14 papers
Wen-Kai Weng
14 papers · 1 as a fellow
Ranjana Advani
12 papers

Grants

Mechanisms of HIV Fitness and Drug Resistance Inferred from High-Resolution Molecular Dynamics and Sequence Co-Variation Models
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.7M · Temple Univ of the Commonwealth
2023–2028
Mapping Fitness & Free Energy Landscapes of Proteins
National Institute of General Medical Sciences · R35
Contact PI · $3.2M · Temple Univ of the Commonwealth
2019–2027
Stanford Cancer Institute
National Cancer Institute · P30
Project lead · $671.8K · Stanford University
2007–2027
Imaging Modulation of Immune Phenotype
National Cancer Institute · R01
PI · $3.2M · Stanford University
2021–2027

Clinical trials

TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
Principal investigator · Completed · Phase 1
Ronald Levy
2018–2024
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
Principal investigator · Completed · Phase 1, Phase 2
Robert Lowsky
2016–2023
A Phase I/II Study of Intratumoral Injection of SD-101
Principal investigator · Completed · Phase 1, Phase 2
Robert Lowsky
2014–2017
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Principal investigator · Completed · Phase 2
Ronald Levy
2009–2017